Browse articles from EyeWorld.org related to NSAIDs. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Positive Phase 3 results in trial investigating topical diabetic macular edema treatment
➤ Positive topline results in Phase 3 trials for retinal vein occlusion treatment
➤ IND filed for drug to treat neuropathic corneal pain
➤ Trial for ‘first-in-class anti-VEGF-complement dual targeting drug’ begins dosing patients
➤ Complimentary access to video journal
➤ ASCRS news and events
The use of NSAIDs in the context of cataract surgery remains a hot topic among surgeons. EyeWorld spoke with two ophthalmologists to hear their current perspectives on NSAID use in cataract surgery.
Newer steroid and NSAID options (and some off-label administration of antibiotics) that are delivered either via injection or intracanalicular insert can help avoid complicating a patient’s drop regimen that is already subject to non-compliance, instillation issues, potential for ocular surface agitation, and more.
Dexycu in the posterior chamber
Source: Michael Savetsky, MD
Cataract surgery anti-inflammatory regimens have changed significantly in the last decade, with an emphasis on improving patient compliance.
